WOCKHARDT
Back to Cashflow Statement
|
WOCKHARDT Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹409 Cr | ₹334 Cr | ₹-315 Cr | ₹-71 Cr | ₹-1,171 Cr |
What is the latest Cash Flow from Financing Activities ratio of WOCKHARDT ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹409 Cr |
Mar2024 | ₹334 Cr |
Mar2023 | ₹-315 Cr |
Mar2022 | ₹-71 Cr |
Mar2021 | ₹-1,171 Cr |
How is Cash Flow from Financing Activities of WOCKHARDT Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹409 Cr | 22.46 | |
Mar2024 | ₹334 Cr | Positive | |
Mar2023 | ₹-315 Cr | Negative | |
Mar2022 | ₹-71 Cr | Negative | |
Mar2021 | ₹-1,171 Cr | - |
Compare Cash Flow from Financing Activities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹25,179.4 Cr | 1.4% | 2.7% | 51.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹388,752.0 Cr | 0.7% | -0.7% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,626.0 Cr | 0.6% | -1.9% | 10.9% | Stock Analytics | |
CIPLA | ₹125,951.0 Cr | -0.1% | -0.3% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,932.0 Cr | -1% | -3% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,414.0 Cr | 0.6% | 3.7% | -1.6% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 1.4% |
2.7% |
51.9% |
SENSEX | 1.6% |
2.6% |
-0.3% |
You may also like the below Video Courses